| Literature DB >> 20357379 |
Elisabeth A Northam1, Ashleigh Lin, Sue Finch, George A Werther, Fergus J Cameron.
Abstract
OBJECTIVE: Type 1 diabetes in youth and community controls were compared on functional outcomes. Relationships were examined between psychosocial variables at diagnosis and functional outcome 12 years later. RESEARCH DESIGN AND METHODS: Participants were subjects with type 1 diabetes (n = 110, mean age 20.7 years, SD 4.3) and control subjects (n = 76, mean age 20.8 years, SD 4.0). The measures used included the Youth Self-Report and Young Adult Self-Report and a semi-structured interview of functional outcomes. Type 1 diabetes participants also provided information about current diabetes care and metabolic control from diagnosis.Entities:
Mesh:
Year: 2010 PMID: 20357379 PMCID: PMC2890334 DOI: 10.2337/dc09-2232
Source DB: PubMed Journal: Diabetes Care ISSN: 0149-5992 Impact factor: 17.152
Figure 1Functional outcomes for subjects with type 1 diabetes and control subjects. LMP, local medical practioner. A high-quality color representation of this figure is available in the online issue.
Baseline predictors of psychosocial, functional, and health outcome for type 1 diabetes group: outcomes
| Outcomes | Internalizing problems at follow-up (regression coefficient) | Externalizing problems at follow-up (regression coefficient) | Total problems at follow-up (regression coefficient) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Explanatory variables | Estimate | 95% CI |
| Estimate | 95% CI |
| Estimate | 95% CI |
|
| CBCL Total problems | 0.33 | 0.13–0.53 | 0.002 | 0.40 | 0.19–0.60 | <0.001 | 0.45 | 0.24–0.66 | <0.001 |
| Gender | 2.77 | −1.55 to 7.10 | 0.2 | −0.87 | −5.26 to 3.52 | 0.7 | 1.21 | −3.32 to 5.74 | 0.6 |
| SES | 1.44 | −0.44 to 3.31 | 0.1 | 0.19 | −1.71 to 2.09 | 0.8 | 0.82 | −1.14 to 2.78 | 0.4 |
| Overall model | |||||||||
| CBCL Internalizing | 0.13 | −0.12 to 0.38 | 0.3 | −0.05 | −0.30 to 0.19 | 0.7 | 0.04 | −0.22 to 0.30 | 0.8 |
| CBCL Externalizing | 0.21 | −0.04 to 0.46 | 0.1 | 0.48 | 0.23–0.73 | <0.001 | 0.42 | 0.16–0.69 | 0.002 |
| Gender | 2.29 | −2.24 to 6.82 | 0.3 | −2.31 | −6.74 to 2.11 | 0.3 | 0.02 | −4.69 to 4.73 | >0.9 |
| SES | 1.49 | −0.44 to 3.42 | 0.1 | 0.05 | −1.84 to 1.94 | >0.9 | 0.78 | −1.23 to 2.79 | 0.4 |
| Overall model | |||||||||
| EAS shyness | 0.72 | −1.23 to 2.66 | 0.5 | −0.40 | −2.12 to 1.33 | 0.7 | 0.04 | −1.90 to 1.97 | >0.9 |
| EAS emotionality | 0.04 | −0.82 to 0.90 | >0.9 | 0.78 | 0.02–1.55 | 0.05 | 0.50 | −0.36 to 1.36 | 0.3 |
| EAS sociability | −0.14 | −1.57 to 1.28 | 0.8 | −0.37 | −1.63 to 0.89 | 0.6 | −0.22 | −1.63 to 1.20 | 0.8 |
| EAS activity | 1.26 | −0.10 to 2.62 | 0.07 | 1.55 | 0.35–2.76 | 0.01 | 1.66 | 0.31–3.02 | 0.02 |
| Gender | 4.74 | 0.29–9.19 | 0.04 | 0.55 | −3.41 to 4.51 | 0.8 | 3.44 | −1.00 to 7.87 | 0.1 |
| Overall model | |||||||||
| FACES cohesion | −1.57 | −2.70 to −0.44 | 0.007 | −0.66 | −1.75 to 0.44 | 0.2 | −1.36 | −2.54 to −0.19 | 0.02 |
| FACES adaptability | 0.00 | −1.19 to 1.19 | >0.9 | −0.32 | −1.47 to 0.83 | 0.6 | 0.18 | −1.06 to 1.41 | 0.8 |
| Gender | 3.01 | −1.20 to 7.22 | 0.2 | −0.83 | −4.92 to 3.25 | 0.7 | 1.37 | −3.01 to 5.76 | 0.5 |
| SES | 0.83 | −1.09 to 2.74 | 0.4 | 0.05 | −1.81 to 1.91 | >0.9 | 0.68 | −1.31 to 2.68 | 0.5 |
| Overall model | |||||||||
R2 value is the adjusted R2. Gender was coded as male = 0, female = 1. Hence in the logistic regression models, males are the baseline category. A higher score on this measure represents lower SES. For analysis, EAS scores were divided by 2, and FACES scores were divided by 3 to aid meaningful interpretation of estimates.
Illness variables and current psychosocial and functional outcomes for type 1 diabetes group
| Outcomes | YSR/YASR Internalizing problems at follow-up (regression coefficient) | YSR/YASR Externalizing problems at follow-up (regression coefficient) | YSR/YASR Total problems at follow-up (regression coefficient) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Explanatory variables | Estimate | 95% CI |
| Estimate | 95% CI |
| Estimate | 95% CI |
|
| Metabolic control | 0.02 | −0.06 to 0.10 | 0.7 | 0.05 | −0.02 to 0.13 | 0.2 | 0.05 | −0.04 to 0.13 | 0.3 |
| Seizure | 3.94 | −0.32 to 8.20 | 0.07 | 5.14 | 1.25–9.02 | 0.01 | 6.0 | 1.77–10.23 | 0.006 |
| Onset of diabetes | −3.56 | −7.97 to 0.85 | 0.1 | −0.19 | −4.22 to 3.84 | >0.9 | −2.46 | −6.85 to 1.92 | 0.3 |
| Gender | 3.76 | −0.53 to 8.05 | 0.09 | −0.85 | −4.76 to 3.07 | 0.7 | 1.92 | −2.34 to 6.17 | 0.4 |
| Overall model | |||||||||
Categorical variables coded as: male = 0, female = 1 (gender); no history of seizure = 0, seizure history = 1 (seizure); later onset diabetes = 0, early onset diabetes = 1 (onset of diabetes); levels coded as 0 are the baseline. For specialist diabetes care and school completion, only participants older than school-leaving age and no longer in pediatric diabetes care were included in analysis (n = 75). Thus, onset of diabetes is not included in this analysis.